These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 16567991)

  • 1. Introduction of tetanus toxoid and reduced diphtheria toxoid vaccines in the United States.
    Mink CM
    Pediatr Infect Dis J; 2006 Apr; 25(4):363-4. PubMed ID: 16567991
    [No Abstract]   [Full Text] [Related]  

  • 2. Extensive swelling reaction associated with diphtheria and tetanus toxoids and acellular pertussis vaccine.
    Sekaran NK; Edwards KM
    Pediatr Infect Dis J; 2006 Apr; 25(4):374-5. PubMed ID: 16567996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules.
    Pichichero ME; Casey JR; Francis AB; Marsocci SM; Murphy M; Hoeger W; Cleary C
    Clin Pediatr (Phila); 2006 Sep; 45(7):613-20. PubMed ID: 16928838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jan; 60(1):13-5. PubMed ID: 21228763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diphtheria, tetanus, and pertussis: Guidelines for vaccine prophylaxis and other preventive measures. Immunization Practices Advisory Committee, Centers for Disease Control.
    Ann Intern Med; 1981 Dec; 95(6):723-8. PubMed ID: 6272621
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy trial of acellular pertussis vaccines; trial I.
    Olin P
    Dev Biol Stand; 1997; 89():52-4. PubMed ID: 9333569
    [No Abstract]   [Full Text] [Related]  

  • 7. Notes from the field : use of tetanus, diphtheria, and pertussis vaccine (Tdap) in an Emergency Department - Arizona, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Jan; 61(3):55-6. PubMed ID: 22278160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccine.
    Baxter R; Hansen J; Timbol J; Pool V; Greenberg DP; Johnson DR; Decker MD
    Hum Vaccin Immunother; 2016 Nov; 12(11):2742-2748. PubMed ID: 27388557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infant pertussis epidemiology and implications for tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination: King County, Washington, 2002 through 2007.
    Hanson MP; Kwan-Gett TS; Baer A; Rietberg K; Ohrt M; Duchin JS
    Arch Pediatr Adolesc Med; 2011 Jul; 165(7):647-52. PubMed ID: 21727277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.
    Gidengil CA; Sandora TJ; Lee GM
    Expert Rev Vaccines; 2008 Jul; 7(5):621-34. PubMed ID: 18564017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures.
    N Y State J Med; 1982 Oct; 82(11):1563-9. PubMed ID: 6959004
    [No Abstract]   [Full Text] [Related]  

  • 12. The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak.
    Talbot EA; Brown KH; Kirkland KB; Baughman AL; Halperin SA; Broder KR
    Vaccine; 2010 Nov; 28(50):8001-7. PubMed ID: 20875487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetanus and pertussis vaccination coverage among adults aged ≥ 18 years --- United States, 1999 and 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Oct; 59(40):1302-6. PubMed ID: 20948508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interchangeability of diphtheria, tetanus, acellular pertussis, polio, Haemophilus influenzae type B combination vaccines presently approved for use in Canada for children < 7 years of age.
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2005 Feb; 31(ACS-1):1-10. PubMed ID: 15895510
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccinations on Reported Pertussis Cases Among Those 11 to 18 Years of Age in an Era of Waning Pertussis Immunity: A Follow-up Analysis.
    Skoff TH; Martin SW
    JAMA Pediatr; 2016 May; 170(5):453-8. PubMed ID: 27018748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of pertussis--are we failing?
    Brunell PA
    Pediatrics; 1985 Oct; 76(4):627-9. PubMed ID: 4047810
    [No Abstract]   [Full Text] [Related]  

  • 17. [Whooping cough--not eradicated, but forgotten].
    Swidsinski S; Schlesinger FL; Mebel S
    Z Arztl Fortbild (Jena); 1989; 83(6):309-12. PubMed ID: 2660433
    [No Abstract]   [Full Text] [Related]  

  • 18. The Gothenburg pertussis vaccine study.
    Trollfors B; Taranger J
    Dev Biol Stand; 1997; 89():49-51. PubMed ID: 9333568
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
    Zepp F; Habermehl P; Knuf M; Mannhardt-Laakman W; Howe B; Friedland LR
    Vaccine; 2007 Jul; 25(29):5248-52. PubMed ID: 17583395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-whooping cough vaccination. Contribution of a case series].
    Borselli L; Giraldi P
    Minerva Pediatr; 1988 Feb; 40(2):91-7. PubMed ID: 3260328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.